| Funding Opportunity ID: |
326372 |
| Opportunity Number: |
BJA-2020-18438 |
| Opportunity Title: |
BJA FY 20 Postconviction Testing of DNA Evidence |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Grant |
| Category of Funding Activity: |
Employment, Labor and Training
Humanities (see “Cultural Affairs” in CFDA)
Information and Statistics
Law, Justice and Legal Services
Science and Technology and other Research and Development |
| Category Explanation: |
|
| CFDA Number(s): |
16.820 |
| Eligible Applicants: |
State governments
County governments
City or township governments
Special district governments
Public and State controlled institutions of higher education |
| Additional Information on Eligibility: |
|
| Agency Code: |
USDOJ-OJP-BJA |
| Agency Name: |
Department of Justice
Bureau of Justice Assistance |
| Posted Date: |
Apr 16, 2020 |
| Close Date: |
Jun 15, 2020 |
| Last Updated Date: |
Apr 16, 2020 |
| Award Ceiling: |
$500,000 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$5,400,000 |
| Expected Number of Awards: |
12 |
| Description: |
The goal of this program is to assist states and units of local government with postconviction DNA testing in cases of violent felony offenses where actual innocence might be demonstrated. Program objectives with respect to target number of cases to be reviewed and other concrete goals must be outlined in the proposal. Funded projects are expected to implement some aspect of each of the following activities, except for case identification, which is not mandatory: 1. Identify potential postconviction DNA testing cases. A maximum of 15 percent of the proposed budget may be dedicated to case identification activities. 2. Review appropriate postconviction cases to identify those in which DNA testing could prove the actual innocence of a person convicted of a violent felony offense as defined by state law. 3. Locate biological evidence associated with such postconviction cases. 4. Perform DNA analysis of appropriate biological evidence. |
| Version: |
1 |
